Equites Radar

CNMD · CONMED Corporation

Medical DevicesUnited StatesAnalyst view: Hold

$42.68

+1.70% last session

End-of-day data · updated 2026-07-28

Mildly bullish3 bullish · 1 bearish technical signals
Consensus: Hold (3.14 from 6 analysts)
To mean target: -8.6%

Market cap

$1B

Enterprise value

$2B

Trailing P/E

24.6

Forward P/E

9.2

Dividend yield

2.0%

Beta

0.93

Avg volume

1M

Employees

4K

2D change

5D change

5.43%

10D change

0.72%

30D change

21.03%

60D change

21.88%

MTD change

32.81%

YTD change

7.17%

Analyst Outlook

Consensus ratingHold
Recommendation mean (1–5)3.14
Covering analysts6
Mean price target$39.00
Low price target$36.00
Upside to mean target-8.6%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)65.1
50-day MA$36.73
200-day MA$39.90
Price vs 50-day MA+20.5%
Price vs 200-day MA+10.9%
MACD histogram0.34
Volume vs 3-month avg1.1×
52w low $32.1152w high $55.60

Analyst sentiment over time — CNMD

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-07-09

Latest call per bank · past 12 months

Bank of America

Underperform

$40.00

-6.3% vs price
Downgrade · 2026-06-29

Wells Fargo

Equal-Weight

$39.00

-8.6% vs price
▼ cut from $42.00Maintains · 2026-05-01

JP Morgan

Neutral

$40.00

-6.3% vs price
▼ cut from $43.00Maintains · 2026-04-30

Recent rating actions

DateFirmActionRatingPrice target
2026-07-09BMO CapitalInitiatesMarket Perform$0.00 $36.00
2026-06-29Bank of AmericaDowngradeNeutralUnderperform$40.00
2026-05-18Bank of AmericaMaintainsNeutral$52.00 $40.00
2026-05-01Wells FargoMaintainsEqual-Weight$42.00 $39.00
2026-04-30JP MorganMaintainsNeutral$43.00 $40.00
2026-03-17Piper SandlerDowngradeOverweightNeutral$55.00 $39.00
2026-01-29Wells FargoMaintainsEqual-Weight$41.00 $42.00
2026-01-29NeedhamReiteratesHold$0.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-28

  • RSI (14): RSI is 65 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 20.5% above the 50-day MA ($36.73).
  • Price vs 200-day MA: Trading 10.9% above the 200-day MA ($39.90).
  • MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • MACD (12,26,9): MACD histogram is positive (+0.34) — short-term momentum is improving.
  • 52-week range: Price sits between the 52-week low ($32.11) and high ($55.60).

CNMD Price Chart

Loading chart for CNMD

Fundamentals

Revenue (TTM)$1.0B
EBITDA$0M
Free cash flow$0M
Operating cash flow$0M
Book value / share$33.76
Net debt / EBITDA3.9
WACC8.0%
Revenue growth-1.00%
Earnings growth137.00%

About CONMED Corporation

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

More in Medical Devices

Screen CNMD against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.